LifeMD, Inc. revised financial guidance for the full year of 2024. For the period, the company expects revenue to be at least $205 million, raised from previous guidance of at least $200 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.22 USD | +9.16% | +3.92% | -0.84% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.84% | 318M | |
-5.63% | 28.92B | |
+28.27% | 8.15B | |
+26.15% | 4.27B | |
-30.37% | 2.53B | |
-8.96% | 1.63B | |
-18.87% | 1.41B | |
-34.19% | 1.14B | |
+5.14% | 904M | |
-41.37% | 838M |
- Stock Market
- Equities
- LFMD Stock
- News LifeMD, Inc.
- LifeMD, Inc. Revises Financial Guidance for the Full Year of 2024